NUAK1 and ovarian carcinoma: Logistic regression modeling (Figure 3A; Table S3 in Supplementary Material) demonstrated a relationship between elevated NUAK1 expression and aggressive clinic-pathologic features, as well as select molecular subtypes in ovarian cancer patients, but not with BRCA1/2 status [odds ratio (OR) = 0.93, p > 0.05].